<?xml version="1.0" encoding="ASCII"?>
<biogps><data><item key="owner">ArrayExpress Uploader</item><item key="pop_total">0</item><item key="id">3300</item><item key="factors"><item><item key="GSM411223"><item key="DONOR">1</item><item key="TREATMENT">control</item></item></item><item><item key="GSM411223"><item key="DONOR">1</item><item key="TREATMENT">control</item></item></item><item><item key="GSM411225"><item key="DONOR">1</item><item key="TREATMENT">rosiglitazone</item></item></item><item><item key="GSM411225"><item key="DONOR">1</item><item key="TREATMENT">rosiglitazone</item></item></item><item><item key="GSM411227"><item key="DONOR">2</item><item key="TREATMENT">control</item></item></item><item><item key="GSM411227"><item key="DONOR">2</item><item key="TREATMENT">control</item></item></item><item><item key="GSM411229"><item key="DONOR">2</item><item key="TREATMENT">rosiglitazone</item></item></item><item><item key="GSM411229"><item key="DONOR">2</item><item key="TREATMENT">rosiglitazone</item></item></item></item><item key="ownerprofile_id">arrayexpress_sid</item><item key="platform">4</item><item key="summary_wrapped">Human CD14 positive monocytes were purified from healthy volunteers&#8217; blood and cultured in vitro for 6 hours. While culturing,...</item><item key="pubmed_id">21093321</item><item key="geo_gse_id">E-GEOD-16386</item><item key="owner_profile">/profile/8773/arrayexpressuploader</item><item key="factor_count">2</item><item key="sample_count">8</item><item key="tags"><item>interleukin</item><item>interleukin-4</item></item><item key="lastmodified">Dec.12, 2014</item><item key="is_default">False</item><item key="geo_id_plat">E-GEOD-16386_A-AFFY-44</item><item key="slug">expression-data-from-human-alternatively-activated</item><item key="geo_gds_id"/><item key="name">Expression data from human alternatively activated macrophages</item><item key="created">Sep.12, 2014</item><item key="summary">Human CD14 positive monocytes were purified from healthy volunteers&#8217; blood and cultured in vitro for 6 hours. While culturing, macrophages were activated alternatively with interleukin-4 (IL-4 100 ng/ml). Simultaneously, macrophages were also treated with vehicle (DMSO:ethanol) or 1uM synthetic PPARg agonist, Rosiglitazone. We used Affymetrix microarrays (U133Plus 2.0) to analyze activation and PPARg-induced gene expression changes. Monocytes from 2 donors were used and treated as indicated in Summary. Technical replicates were generated from each sample.</item><item key="source">http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-16386</item><item key="species">human</item><item key="sample_source">http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-16386/samples/</item></data></biogps>
